AI-generated analysis. Always verify with the original filing.
PTC Therapeutics, Inc. filed an 8-K on February 19, 2026, disclosing results of operations under Item 2.02 and Regulation FD disclosure under Item 7.01. The Company will host a conference call at 4:30 p.m. eastern time on that date, as previously announced, with Exhibit 99.1 being the related press release.
Event Type
Disclosure
Mandatory
Variant
8-K
. Item 7.01. Regulation FD Disclosure. The Company will host a conference call on February 19, 2026 at 4:30 p.m. eastern time, as previously announced. During t
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated February 19, 2026 issued by PTC Therapeutics,